Mohamed brings expertise in translating biotechnological innovation to business strategy and commercial planning. As a consultant at ClearView Healthcare Partners, he was a strategic advisor to big pharma companies as well as early-stage biotechs at various stages of platform and asset development maturity. He then worked as a corporate strategy lead at a biotech company developing novel therapeutic modalities, interfacing with cross-functional scientific, clinical and commercial teams. Mohamed holds a B.S. in bioengineering from Harvard University.